Variable (mean or mean, n, %) | Phase 0 (n = 260) | Phase 2(n = 260) | p value |
---|---|---|---|
Retained Blood (composite) | 60 (23%) | 25 (9.6%) | <.001 |
Re-exploration | 6 (2.3%) | 2 (0.77%) | .29 |
Pleural Intervention-Percutaneous | 57 (22%) | 21 (8.1%) | <.001 |
Pleural Intervention- Surgical | 2 (0.77%) | 0 (0%) | 0.25 |
Pericardial Intervention | 4 (1.5%) | 4 (1.5%) | 1 |
# Pleural Effusions drained | 139 | 53 | .002 |
POAF | 79 (37%) (n = 214) | 55 (25%) (n = 216) | .011 |
Cardiac arrest | 8 (3.1%) | 5 (1.9%) | .58 |
Postoperative blood products used | 60 (23%) | 48 (18%) | .2 |
CT output (mL) first 24 h | 753 [584–975] | 678 [539–950] | .038 |
Total CT output (mL) | 1152 [854–1656] | 1038 [760–1431] | .020 |
Total CT (days) | 3 [3–4] | 2 [2–2] | <.001 |
Infection (any) | 37 (14%) | 10 (3.8%) | <.001 |
Surgical site deep | 0 (0%) | 0 (0%) | 1 |
Surgical site superficial | 0 (0%) | 0 (0%) | 1 |
Surgical site mediastinitis | 0 (0%) | 0 (0%) | 1 |
Pneumonia | 20 (7.7%) | 4 (1.5%) | .0022 |
Septicemia | 4 (1.5%) | 0 (0%) | .062 |
UTI | 10 (3.8%) | 4 (1.5%) | .18 |
C. Diff | 3 (1.2%) | 1 (0.38%) | .62 |
Highest postoperative creatinine | 1.1 [1–1.4] | 1.0 [0.8–1.2] | <.001 |
AKI Stage 1 | 78 (30%) (n = 257) | 44 (17%) (n = 256) | .0014 |
AKI Stage 2 | 7 (2.7%) (n = 257) | 4 (1.6%) (n = 256) | .55 |
AKI Stage 3 | 3 (1.2%) (n = 257) | 1 (0.39% (n = 256) | .62 |
Postoperative renal dialysis | 7 (2.7%) | 0 (0%) | .0078 |
Stroke | 2 (0.77%) | 2 (0.77%) | 1 |
Mortality | 7 (2.7%) | 7 (2.7%) | 1 |